✦ LIBER ✦

Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial

✍ Scribed by Yolande Lievens; Karin Haustermans; Danielle Van den Weyngaert; Walter Van den Bogaert; Pierre Scalliet; Liesbeth Hutsebaut; Jack Fowler; Philippe Lambin

Book ID: 119521968
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 79 KB
Volume: 47
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(97)00231-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

152Does sucralfate reduce the acute side

152Does sucralfate reduce the acute side effects in head and neck cancer treated with radiotherapy? A double blind randomized trial

✍ Lievens, Y.; Haustermans, K.; Van den Weyngaert, D.; Van den Bogaert, W.; Scalli 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 117 KB

832 Poster Subcutaneous amifostine. Does

832 Poster Subcutaneous amifostine. Does it reduce the acute toxicity of a concomitant chemoradiation scheme in advanced head and neck cancer? Preliminary results of a randomized clinical trial

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Doxepin Rinse Versus Placebo in the Trea

Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy With or Without Chemotherapy: A Phase III, Randomized, Double-Blind Trial (NCCTG-N09C6 [Alliance])

✍ Leenstra, J. L.; Miller, R. C.; Qin, R.; Martenson, J. A.; Dornfeld, K. J.; Bear 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 286 KB

Results from the Multi-institutional, Ra

Results from the Multi-institutional, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy of a Mucoadhesive Hydrogel Rinse in Mitigating Oral Mucositis (OM) in Chemoradiation-Treated (CRT) Head-and-Neck Cancer (HNC) Patients

✍ Nowotnik, D.P.; Allison, R.R.; Arshoun, Y.M.; Carmel, R.; Ciuba, D.F.; Feldman, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Therapeutic effect of recombinant human

Therapeutic effect of recombinant human epidermal growth factor (rhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer : A double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial

✍ Hong Gyun Wu; Si Yeol Song; Yeon Sil Kim; Young Taek Oh; Chang Geol Lee; Ki Chan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 2 views

Comparison of the efficacy and safety of

Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis : A prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer

✍ Rene-Jean Bensadoun; Jamel Daoud; Brahim El Gueddari; Laurent Bastit; Rene Gourm 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

## Abstract ## BACKGROUND. Topical antifungal treatments are recommended but rarely used as first‐line therapy for oropharyngeal candidiasis (OPC) in patients with cancer. Miconazole Lauriad 50‐mg mucoadhesive buccal tablet (MBT) Loramyc reportedly delivered rapid and prolonged, effective concentr